Key result
H2FPEF outperforms HFA-PEFF for ruling out HFpEF with ~98% sensitivity, but lags for rule-in.
Why the study?
Noninvasive diagnosis of HFpEF remains challenging, and the diagnostic performance of the H2FPEF and HFA-PEFF scores across clinical settings and patient subgroups had not been systematically compared.
Do the H2FPEF and HFA-PEFF scores accurately rule in and rule out heart failure with preserved ejection fraction (HFpEF) across 3,813 participants?
Meta-Analysis (n=3,813)
Yes
Do the H2FPEF and HFA-PEFF scores accurately rule in and rule out heart failure with preserved ejection fraction (HFpEF) across 3,813 participants?
In the noninvasive evaluation of HFpEF, the H2FPEF score is superior for ruling out the diagnosis (AUC 0.95), whereas the HFA-PEFF score performs better for ruling it in (AUC 0.75).
H2FPEF excels at ruling out HFpEF while HFA-PEFF is better for ruling in; extends evidence for complementary noninvasive use.
Background Heart failure with preserved ejection fraction (HFpEF) is a heterogeneous clinical syndrome, and noninvasive diagnosis remains challenging. The H2FPEF and HFA-PEFF scores are increasingly used for diagnostic evaluation; however, their performance across clinical settings and patient subgroups has not been systematically compared. Methods We systematically searched PubMed, Embase, the Cochrane Library, and ClinicalTrials.gov from inception to October 5, 2025. A bivariate random-effects model was applied to pool sensitivity and specificity, and hierarchical summary receiver operating characteristic (HSROC) analysis was performed for rule-out and rule-in cut-offs. Subgroup and sensitivity analyses were conducted to explore heterogeneity. Results A total of 11 studies comprising 3813 participants were included. For the H2FPEF score, the pooled sensitivity at the rule-out cut-off was 98% (95% CI, 96%–99%), and the pooled specificity at the rule-in cut-off was 90% (95% CI, 74%–97%). The HSROC area under the curve (AUC) was 0.95 (95% CI, 0.92–0.96) for the rule-out cut-off and 0.65 (95% CI, 0.61–0.69) for the rule-in cut-off. For the HFA-PEFF score, the pooled sensitivity at the rule-out cut-off was also 98% (95% CI, 95%–99%), and the pooled specificity at the rule-in cut-off was 87% (95% CI, 76%–94%), with corresponding AUCs of 0.63 (95% CI, 0.59–0.67) and 0.75 (95% CI, 0.71–0.78). Conclusion The H2FPEF score was more effective for ruling out HFpEF, whereas the HFA-PEFF score performed better for ruling in the diagnosis. Diagnostic performance varied across subgroups, with particularly cautious interpretation required in obese patients.
No takes yet. Share an insight, caveat, or question.
Lou et al. (2026) conducted a meta-analysis in Heart failure with preserved ejection fraction (HFpEF) (n=3,813). H2FPEF score vs. HFA-PEFF score was evaluated on Diagnostic sensitivity and specificity for ruling out and ruling in HFpEF (Rule-out AUC 0.95 vs 0.63; Rule-in AUC 0.65 vs 0.75, 95% CI 0.92-0.96). The H2FPEF score outperformed HFA-PEFF for ruling out HFpEF (AUC 0.95 vs 0.63; sensitivity 98%), while HFA-PEFF was superior for ruling in HFpEF (AUC 0.75 vs 0.65; specificity 87% vs 90%).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: